Chester County News and Community Website
PLYMOUTH MEETING, PA — INOVIO Pharmaceuticals, Inc. (Nasdaq: INO) has announced plans to conduct an underwritten public offering of its common stock, or pre-funded warrants in lieu of common stock, …
INOVIO Announces Public Offering of Common Stock and Warrants Read More
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has announced the pricing of its underwritten public offering, aiming to raise approximately $100 million in gross proceeds. The offering comprises 39,200,000 …
Cabaletta Bio Prices Public Offering to Raise $100 Million Read More PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced today it has started an underwritten public offering of common stock and accompanying warrants (or pre-funded warrants in lieu of common …
Cabaletta Bio Announces Public Offering of Common Stock and Warrants Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) today announced the pricing of its underwritten public offering of 8,000,000 shares of common stock at $2.25 per share. The offering is expected …
Neuronetics Prices Public Offering of Common Stock at $2.25 Per Share Read More
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) has announced the completion this week of its underwritten public offering, generating $21 million in gross proceeds. The offering consisted of 5,250,000 shares …
Annovis Bio Raises $21 Million in Public Offering to Advance Alzheimer’s Research Read More MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) has revealed plans to conduct an underwritten public offering of common stock and warrants. The company will sell all offered securities directly, with …
Annovis Bio Announces Public Offering of Common Stock and Warrants Read More
MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) announced the successful closing of its public offering of 30,434,783 shares of common stock on Friday. Each share was sold at $1.15, generating …
Ocugen Closes $35 Million Public Offering on Friday Read More MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) launched a public offering of its common stock on July 31, 2024. The company also plans to grant the underwriter a 30-day option …
Ocugen Announces Public Offering of Common Stock Read More
BALA CYNWYD, PA — The biotech firm Larimar Therapeutics, Inc. (Nasdaq: LRMR) recently announced that it has successfully closed an underwritten public offering. The company sold 19,736,842 shares of its …
Larimar Therapeutics Raises $172.5 Million in Public Offering to Propel Rare Disease Research Read More BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR), a Pennsylvania-based clinical-stage biotechnology company specializing in treatments for complex rare diseases, announced this week that it has launched an underwritten …
Larimar Therapeutics Announces Underwritten Public Offering of Common Stock and Pre-Funded Warrants Read More